All Sauce from Weekly Sauce:

If you’re one of the millions of people with a common heart rhythm disorder called atrial fibrillation (a-fib), losing weight before treatment may increase the odds that your a-fib doesn’t come back. In a new study, patients with a-fib who were overweight or obese when they underwent ablation to correct their abnormal heart rhythm were…  read on >  read on >

An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country’s current shots. “As we prepare for future needs to address COVID-19, prevention in the form of vaccines remains our best defense…  read on >  read on >

Israel’s government made a second booster dose of the Pfizer vaccine available to all of its citizens aged 60 and older at the beginning of this year. Now, emerging data suggests this fourth dose greatly boosts protection against the Omicron variant. In a study published April 5 in the New England Journal of Medicine, researchers…  read on >  read on >

Vaccines did a good job protecting most cancer patients against COVID-19, but those with blood cancers remain at risk for breakthrough infections, new research suggests. The study analyzed nationwide data on more than 64,000 U.S. cancer patients who were vaccinated against SARS-CoV-2. The researchers looked at types of cancer, key treatments and other risk factors,…  read on >  read on >

A proposed rule to ban ongoing uses of the only known form of asbestos imported into the United States has been introduced by the U.S. Environmental Protection Agency (EPA). The ban would apply to chrysotile asbestos, which is known to cause cancer and is found in products like asbestos diaphragms, sheet gaskets, brake blocks, aftermarket…  read on >  read on >